Table 1. Baseline characteristics of patients.
| Endoscopic resection (n=262) | Laparoscopic resection (73) | P value | ||
|---|---|---|---|---|
| Age | Median (Range) | 58 (23-81) | 60 (28-83) | |
| Mean±SD | 57.00±10.32 | 57.95±11.89 | 0.540 | |
| Gender | Male (n=136) | 106 | 30 | 1.000 |
| Female (n=199) | 156 | 43 | ||
| Symptoms | Abdominal pain (n=193) | 157 | 36 | 0.965 |
| Bleeding (n=16) | 4 | 12 | ||
| Others (n=56) | 47 | 9 | ||
| No symptoms (n=70) | 54 | 16 | ||
| Combined with ulceration | Yes (n=18) | 6 | 12 | 0.130 |
| No (n=313) | 252 | 61 | ||
| Tumor location | Gastric fundus (189) | 154 | 35 | 0.827 |
| Gastric body (85) | 59 | 26 | ||
| Gastric antrum (14) | 7 | 21 | ||
| Gastric cardia (39) | 34 | 5 | ||
| Tumor size (cm) | Mean±SD | 1.33±0.78 | 1.97±0.93 | 0.000 |
| Mitotic rate (per 50 HPF) | ≤5cm (83) | 59 | 24 | 0.255 |
| 5-10cm (20) | 16 | 4 | ||
| >10cm (2) | 2 | 0 | ||
| CD34 positive | Yes (n=247) | 183 | 64 | 0.653 |
| No (n=6) | 4 | 2 | ||
| CD117 positive | Yes (n=241) | 178 | 63 | 1.000 |
| No (n=12) | 9 | 3 | ||
| NIH risk classification | Very low risk (0) | 0 | 0 | 0.255 |
| Low risk (179) | 124 | 55 | ||
| Intermediate risk (14) | 11 | 3 | ||
| High risk (2) | 2 | 0 |
CD34, CD34 protein; CD117, CD117 protein;HPF, High-power field; NIH, National Institutes of Health; SD, standard deviation.